Sanofi

Portfolio Companies 2026 for Sanofi: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Sanofi accounts for 21 tracked companies with verified cap-table data, 21 of which disclose round sizes totalling $7B. The median disclosed raise is $135M, and the largest is Dynavax Technologies at $2.2B, ahead of Earendil Labs ($787M) and MapLight Therapeutics ($699M).

The names that recur most often on these portfolio cap tables are Sanofi (21 companies), Forbion (2 companies), a16z (2 companies), Biogen (2 companies), Redmile Group (2 companies), Dimension Capital (1 company). By latest disclosed round, the market skews Series B (8), Series D (4), Series A (4), IPO (2).

Best funded Sanofi companies

  1. Dynavax Technologies — $2.2B (latest: IPO)
  2. Earendil Labs — $787M (latest: Series B)
  3. MapLight Therapeutics — $699M (latest: Series D)
  4. MeiraGTx — $585M (latest: IPO)
  5. TrialSpark — $568M (latest: Series D)
  6. Nature’s Medicines — $372M
  7. Denali Therapeutics — $349M (latest: Series A)
  8. Owkin — $334M (latest: Series B)
  9. Enveda Biosciences — $230M (latest: Series D)
  10. AgomAb Therapeutics — $189M (latest: Series D)
  11. Expansion Therapeutics — $135M (latest: Series B)
  12. Sensorion — $116M (latest: Growth)
  13. Altesa — $79M (latest: Series B)
  14. Enable Injections — $78M (latest: Series B)
  15. Zucara Therapeutics — $50M (latest: Series B)

Sanofi Ventures — related firms and companies (51)

Sanofi Ventures profile · All research reports